Regina Schaffer (@reginaschaffer.bsky.social)

Some patients on cancer therapy may have increased risk for uveitis FORT LAUDERDALE, Fla. — Patients being treated with immune checkpoint inhibitors may be at higher risk for developing uveitis, according to a speaker at Retina World Congress. Charlie Zhang, MD, said uveitis has been an uncommon side effect of cancer treatment, but there has been a shift as the use of immune checkpoint inhibitors (ICIs) has become more common. “Clinically, the major adverse effects of these drugs is the spectrum of immune-related adverse dysregulation, with the eye being one of the many organs affected,” Zhang said. Zhang and colleagues analyzed data from 157,493 patients on ICI http://dlvr.it/TSXv3q